Relevant to the discussion: 

* Cell, Vol. 110, 551–561, September 6, 2002, Copyright 2002 by Cell Press 
An RNA Thermosensor Controls Expression of Virulence Genes in Listeria 
monocytogenes 

* Bacterial RNA thermometers: molecular zippers and switches 
Jens Kortmann and Franz Narberhaus 
NATURE REVIEWS | MICROBIOLOGY VOLUME 10 | APRIL 2012 | 255 

*An RNA Thermometer Activity of the West Nile Virus Genomic 30-Terminal 
Stem-Loop Element Modulates Viral Replication Eciency during Host Switching 
Viruses 2020, 12, 104; doi:10.3390/v12010104 

* Temperature triggers immune evasion by Neisseria meningitidis 
Edmund Loh1*, Elisabeth Kugelberg2*, Alexander Tracy1, Qian Zhang2, Bridget 
Gollan2, Helen Ewles2, Ronald Chalmers3, 
Vladimir Pelicic2 & Christoph M. Tang1,2 
Nature (2013) 

Philippe Dumas 

De: "James Holton" <jmhol...@lbl.gov> 
À: "CCP4BB" <CCP4BB@JISCMAIL.AC.UK> 
Envoyé: Dimanche 22 Mars 2020 16:38:28 
Objet: Re: [ccp4bb] CCP4BB vs COVID19 

Thank you Patrick, 

RNA structure is still structural biology, so I think relevant here. It seems 
to me that RNA as a thermometer would be an easy hypothesis to test? Has anyone 
measured virulence vs temperature in cell culture? 

The 3D structure of the genome is no doublt important. I wouldn't want to try 
crystallizing the whole thing, but I wonder if this might be an excellent 
target for cryoEM? A challenge for that "we can classify our way out of 
anything" philosophy? And the result would most certainly be interesting. 

-James Holton 
MAD Scientist 

On 3/21/2020 8:41 AM, Patrick Shaw Stewart wrote: 




James, this isn't conventional structural biology, but may be of interest, and 
I haven't been able get any mainstream virologists to think about it. 

The protein sequences are obviously of interest, but so are the RNA sequences 
at both ends of the Covid genome, which have conserved secondary structure. A 
few years ago a paper came out suggesting that wild-type influenza has multiple 
"RNA thermometers", which may play an important role in the tropism of 
influenza. Similar mechanisms may exist in other respiratory viruses, including 
Covid. 

My take on this, and the relevant papers, are below. 

Good luck to everyone and stay well, 

Patrick 



BQ_BEGIN

[ 
https://oldwivesandvirologists.blog/Covid-19-and-the-trade-off-model-of-selection/
 | 
https://oldwivesandvirologists.blog/Covid-19-and-the-trade-off-model-of-selection/
 ] 

My paper in Medical Hypotheses [ 
http://douglas.co.uk/f_ftp1/ShawStewart_final_1-s2.pdf | 
http://douglas.co.uk/f_ftp1/ShawStewart_final_1-s2.pdf ] 

Narberhaus, Franz, Torsten Waldminghaus, and Saheli Chowdhury. "RNA 
thermometers." FEMS microbiology reviews 30.1 (2006): 3-16. 

Chursov, Andrey, et al. "Specific temperature-induced perturbations of 
secondary mRNA structures are associated with the cold-adapted 
temperature-sensitive phenotype of influenza A virus." RNA biology 9.10 (2012): 
1266-1274. 

Yang, Dong, and Julian L. Leibowitz. "The structure and functions of 
coronavirus genomic 3′ and 5′ ends." Virus research 206 (2015): 120-133. 





On Fri, Mar 20, 2020 at 10:59 PM James Holton < [ mailto:jmhol...@lbl.gov | 
jmhol...@lbl.gov ] > wrote: 

BQ_BEGIN
You might think that as a structural biologist you won't be able to do 
much about COVID-19 anytime soon, but that is not true. Yes, real-world 
therapeutics and vaccines take time, but we have already seen just how 
fast we can get started. There are 21 PDBs already and some even have 
bound ligands. Good job Frank et al. BTW! And my personal thanks to 
all of you out there who are already hard at work on this. 

I believe this forum is an ideal place to share information and ideas on 
the structural biology of SARS-CoV-2 as we move forward. It's a big 
virus, but there are not that many proteins in it. If all of us 
independently do the same bioinformatics and literature searches and end 
up trying exactly the same thing in every lab all over the world, then 
that would be more than unfortunate. To that end, I am personally 
interested on ORF8 for reasons I will go into below. Has anyone tried 
to solve it yet? What happened? Didn't express? Bad diffraction? 
What? Do tell. 

Some of us, as you may have heard, are stuck at home, our beamlines and 
labs dark while we shelter-in-place. That doesn't mean our hands are 
tied. We are still allowed to think. The fraction of the human race 
that has a snowball's chance in Hades of figuring out this bug is very 
very small. Structure may be your main skill set, but you are still a 
biologist. Do you know how to run a PCR machine? Do you know how to 
pipette? You might think that anybody can do it, but that is really not 
the case. Ever trained a new student on sterile technique? How many 
days did that take? Now remember that your student was no dummy and 
already studying biology. Everyone reading this will make an excellent 
volenteer at the very least. I'm not saying this to belittle the 
average human, only to say that we scientists, moving in the circles we 
do, often forget that we have uncommon capabilities. 

For example, I also believe we can be useful in assay development. The 
void left by the dearth and delay of test results has been filled with 
fear, and that is a big problem. The tests, as defined, are 
straightforward, but also extremely regimented like any good laboratory 
protocol should be. The US CDC's instructions for academic labs are here: 
[ https://www.cdc.gov/coronavirus/2019-nCoV/lab/index.html | 
https://www.cdc.gov/coronavirus/2019-nCoV/lab/index.html ] 
My question is: how can this test be made faster, using more commonplace 
supplies, in high-throughput mode and still valid? Not just for 
clinical but for academic use? I think more than a few people on this 
list could be regarded as experts in making a complex biochemical task 
faster, more efficient, high-throughput and nonetheless valid. Yes, 
there are other people who do virus testing for a living, but right now 
they are all rather busy. Maybe if we put our minds to it we can help? 

As for why ORF8. I am basing my interest on the bioinformatics done in 
this article: [ https://dx.doi.org/10.1093/nsr/nwaa036 | 
https://dx.doi.org/10.1093/nsr/nwaa036 ] . Search for 
"T8517C" and you will find what I'm talking about. The authors found 
two "types" of SARS-CoV-2. They call them "S" and "L" because the only 
conserved amino acid change involved is S84L in ORF8. The "S" type is 
believed to be the ancestor of "L". What is interesting is how tightly 
linked this mutation is to a silent mutation on the other end of the 
genome: the "L" type has a faster codon for Ser in ORF1. Such tight 
coupling (r^2=0.945) means there must be significant selective pressure 
preventing both of these mutations occurring in the same virus at the 
same time. That, I believe, is interesting. Espeically since they are 
so far apart I expect this selective pressure might work in trans: as in 
a super-infection. That is, the S and L genome types may interfere with 
each other. 

The authors fall short of claiming evidence of interference upon 
super-infection, and indeed they have already been criticised for 
calling "L" the "aggressive" type. But it is still interesting and 
points a finger at ORF8. 

ORF8 has only one homolog in the PDB: 5o32 with 25% identity over a 
stretch of 60 residues. This homologous region contains the S84L site 
(Val I544 in 5o32). I had a quick look and appears to be a 
cavity-filling mutation to me. Not very big, but maybe something could 
fit in there. To be sure we'd need a structure of ORF8. 

Good luck to you all, and stay healthy. 

-James Holton 
MAD Scientist 

######################################################################## 

To unsubscribe from the CCP4BB list, click the following link: 
[ https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1 | 
https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1 ] 

BQ_END



-- 
[ mailto:patr...@douglas.co.uk | patr...@douglas.co.uk ] Douglas Instruments 
Ltd. 
Douglas House, East Garston, Hungerford, Berkshire, RG17 7HD, UK 
Directors: Patrick Shaw Stewart, Peter Baldock, Stefan Kolek 

[ http://www.douglas.co.uk/ | http://www.douglas.co.uk ] 
Tel: 44 (0) 148-864-9090 US toll-free 1-877-225-2034 
Regd. England 2177994, VAT Reg. GB 480 7371 36 

BQ_END





To unsubscribe from the CCP4BB list, click the following link: 
[ https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1 | 
https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1 ] 

########################################################################

To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1

Reply via email to